1-3 of 3
Janusz S. Kloczko
Close
Sort by
Journal Articles

Influence of Chromosomal Aberrations on Response to First Line Therapy in B-Cell Chronic Lymphocytic Leukemia: Interim Analysis of PALG-CLL3 Randomized Study Comparing Cladribine Plus Cyclophosphamide vs Fludarabine Plus Cyclophosphamide.

Tadeusz Robak, Jerzy Z. Blonski, Ewa Wawrzyniak, Aleksandra Palacz, Joanna Gora-Tybor, Krzysztof Jamroziak, Jaroslaw Piszcz, Janusz S. Kloczko, Dorota Koczkodaj, Malgorzata Kowal, Anna Dmoszynska, Andrzej Mital, Andrzej Hellmann
Journal: Blood
Blood (2007) 110 (11): 2046.
https://doi.org/10.1182/blood.V110.11.2046.2046
Published: 2007
Journal Articles

Quantitative RT-PCR Assessment of Cannabinoid Receptor CB2 and Fatty Acid Amine Hydrolase in Neoplastic Cells of Patients with B-Cell Chronic Lymphocytic Leukaemia.

Jaroslaw A. Piszcz, MD, PhD, Janusz S. Kloczko, MD, PhD, Slawomir Ziarko, MSc, Piotr Radziwon, MD, PhD, Katarzyna Z. Mazgajska-Barczyk, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 4995.
https://doi.org/10.1182/blood.V106.11.4995.4995
Published: 2005
Journal Articles

Expression of Cannabinoid Receptors on the Neoplastic Lymphocytes in Patients with Chronic Lymphocytic Leukemia.

Jaroslaw A. Piszcz, Miroslawa Pietruczuk, Janusz S. Kloczko, Milena Dabrowska, Marzenna Galar, Marek P. Milewski
Journal: Blood
Blood (2004) 104 (11): 4804.
https://doi.org/10.1182/blood.V104.11.4804.4804
Published: 2004